Kester Capital-backed MAP Patient Access completed the acquisition of AxTalis.

Kester Capital-backed MAP Patient Access, a company in market access consulting services to the pharmaceutical and biotech sectors, completed the acquisition of AxTalis, a consultancy firm supporting Biopharma and Medtech companies in Regulatory Affairs, Market Access and Medical Affairs. Financial terms were not disclosed. "We are excited to become part of the Group. This acquisition opens up new opportunities for us to deliver even greater value to our clients. Together, we will continue to drive positive change and broaden access to therapeutic solutions through collaboration with physicians, researchers, companies, health authorities and patients," Sven Tops and Frank Vanderdonck, AxTalis Co-Founders and Managing Partners.